These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18301396)

  • 1. Therapeutic potential of statins in thyroid proliferative disease.
    Bifulco M
    Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):242-3. PubMed ID: 18301396
    [No Abstract]   [Full Text] [Related]  

  • 2. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
    McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
    Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins sentence thyroid cancer cells to death rho.
    Robbins RJ
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3019-20. PubMed ID: 12843137
    [No Abstract]   [Full Text] [Related]  

  • 4. Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
    Ogunwobi OO; Beales IL
    Am J Gastroenterol; 2008 Apr; 103(4):825-37. PubMed ID: 18371146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins activate a mitochondria-operated pathway of apoptosis in breast tumor cells by a mechanism regulated by ErbB2 and dependent on the prenylation of proteins.
    Herrero-Martin G; López-Rivas A
    FEBS Lett; 2008 Jul; 582(17):2589-94. PubMed ID: 18582466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gift from nature: the birth of the statins.
    Endo A
    Nat Med; 2008 Oct; 14(10):1050-2. PubMed ID: 18841147
    [No Abstract]   [Full Text] [Related]  

  • 7. Statins in esophageal cancer cell lines: promising lead?
    Hawk ET; Viner JL
    Am J Gastroenterol; 2008 Apr; 103(4):838-41. PubMed ID: 18371147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evidence of duality effects for lovastatin in a nude mouse cancer model.
    Wang CY; Shui HA; Chang TC
    Int J Cancer; 2010 Jan; 126(2):578-82. PubMed ID: 19621388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma.
    Kim W; Yoon JH; Kim JR; Jang IJ; Bang YJ; Kim YJ; Lee HS
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):497-507. PubMed ID: 19096848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lovastatin potentiates antitumor effects of saquinavir against human lymphoma cells.
    Issat T; Nowis D; Jakóbisiak M; Golab J
    Oncol Rep; 2004 Dec; 12(6):1371-5. PubMed ID: 15547765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins in tumor suppression.
    Sassano A; Platanias LC
    Cancer Lett; 2008 Feb; 260(1-2):11-9. PubMed ID: 18180097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and Thyroid Carcinoma: a Meta-Analysis.
    Zhao J; Xu C; Yao J; Yu C; Liao L; Dong J
    Cell Physiol Biochem; 2018; 47(4):1422-1431. PubMed ID: 29929194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of RhoA enhances peritoneal dissemination: RhoA suppression with Lovastatin may be useful for ovarian cancer.
    Horiuchi A; Kikuchi N; Osada R; Wang C; Hayashi A; Nikaido T; Konishi I
    Cancer Sci; 2008 Dec; 99(12):2532-9. PubMed ID: 19038009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins as a new therapeutic approach in dedifferentiated thyroid cancer?
    Hofman A; John P; Schaffarich MP; Sinzinger H; Staudenherz A
    Nuklearmedizin; 2006; 45(3):N28-30. PubMed ID: 16755692
    [No Abstract]   [Full Text] [Related]  

  • 15. Lovastatin enhances the antitumoral and apoptotic activity of doxorubicin in murine tumor models.
    Rozados VR; Hinrichsen LI; Binda MM; Gervasoni SI; Matar P; Bonfil RD; Scharovsky OG
    Oncol Rep; 2008 May; 19(5):1205-11. PubMed ID: 18425377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta-Smad3 pathway.
    Kaji H; Naito J; Inoue Y; Sowa H; Sugimoto T; Chihara K
    Horm Metab Res; 2008 Nov; 40(11):746-51. PubMed ID: 18622892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New approaches to the drug prophylaxis of mammary tumor: evaluation of the prophylactic effect of lovastatin and captopril in rats with experimental mammary gland tumors].
    Chochieva AR; Bolieva LZ; Dzhioev FK
    Eksp Klin Farmakol; 2008; 71(1):43-5. PubMed ID: 18365487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of the HMG-CoA reductase inhibitor lovastatin and nitric oxide in cardiomyocyte cell death.
    Rabkin SW; Tsang MY
    Pharmacology; 2008; 82(1):74-82. PubMed ID: 18504415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human caspase 7 is positively controlled by SREBP-1 and SREBP-2.
    Gibot L; Follet J; Metges JP; Auvray P; Simon B; Corcos L; Le Jossic-Corcos C
    Biochem J; 2009 May; 420(3):473-83. PubMed ID: 19323650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lovastatin induces the formation of abnormal myelin-like membrane sheets in primary oligodendrocytes.
    Maier O; De Jonge J; Nomden A; Hoekstra D; Baron W
    Glia; 2009 Mar; 57(4):402-13. PubMed ID: 18814266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.